Nirmal Mulye

Dr. Nirmal Mulye is the Founder and Chairman of the Nostrum Group with over a dozen foundational patents to his name. Dr. Mulye started Nostrum Pharmaceuticals in 1995 after graduating with his doctorate and a focus on thermodynamics.

In 2008, Dr. Mulye became interested in alternative energy and fuels, and founded Nostrum Energy. One of the first products Mulye conceived was what is now known as the Kinetic Direct Injector which uses the same methodology as Mulye’s patented nebulizers, which delivers the medication in a fine particle mist that can be inhaled. Since then, Nostrum has grown to include 5 subsidiaries which paved the path for research and development in Fuel and Energy.